New search Hide text from Guidelines
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSThis group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.
L03 IMMUNOSTIMULANTS
Immunosuppressants, see L04A.
L03A IMMUNOSTIMULANTS
Levamisole, which also affects the immune response, is classified in P02CE.
L03AX Other immunostimulants
| The DDD for tasonermin is based on single dose treatment. The DDD of 0.5 mg (P) for histamine dihydrochloride is based on the total dose devided by days of first treatment cycle (42 days). |
| ATC code | Name | DDD | U | Adm.R | Note |
| L03AX16 | plerixafor | 16.8 | mg | P |
Last updated: 2024-01-26